Residual Clot in Patients with Deep Vein Thrombosis and Pulmonary Embolism: Prognostic Implications

Journal Title: Journal of Hematology & Thrombosis - Year 2015, Vol 1, Issue 1

Abstract

In order to assess whether there is discordance in the timing of thrombus resolution between deep vein thrombosis (DVT) and pulmonary embolism (PE), we analyzed current evidence from recent major literature, and evaluated its prognostic implications. After an episode of proximal DVT, residual vein thrombosis (RVT), as shown with ultrasonography, is still detectable in approximately 50% of patients after three months, and in lower proportions afterwards. RVT is likely to represent a marker of hypercoagulability, and is associated with an approximately doubled risk for recurrent thromboembolism, post-thrombotic syndrome, arterial thrombotic events and cancer. Males, individuals with extensive thrombosis and those with previous thromboembolism have the highest likelihood of developing RVT. Conversely, based on recent findings in 85% of patients with PE a full recanalization, as shown by CT scanning, is achieved, and in the remaining patients the thrombotic mass decreases by 80%. No association exists between residual embolism and the risk for recurrent thromboembolism or chronic thromboembolic pulmonary hypertension. Accordingly, repeating CT scanning for prognostic implications does not seem justified. These findings add to the growing perception that DVT and PE are to be regarded as separate pathophysiological entities.

Authors and Affiliations

Paolo Prandoni

Keywords

Related Articles

The Promise and Challenges of Personalized Medicine in Hematologic Malignancies

Personalized medicine is a rapidly emerging medical model that proposes individually customized healthcare to potentially increase the quality of clinical care and reduce health care costs. The key to the success of pers...

Differences in Circulating Endothelial Progenitor Cells among Childhood Cancer Survivors Treated with and without Radiation

Radiation during childhood cancer treatment increases the propensity to atherosclerotic cardiovascular disease among adult survivors of childhood cancer. This is thought to be mediated through the damage to the underlyin...

Hypoplasia of Infrarenal Inferior Vena Cava: An Infrequent Cause of Repetitive Deep Vein Thrombosis and its Effects

Congenital anomalies such as the defects of inferior vena cava (IVC) are not common, however these alterations obtained from a poor embryo development benefit venous stasis which, inconsequence, will trigger a deep vein...

The Application of Holotranscobalamin and Methylmalonic Acid in Hospital Patients and Total Vitamin B12 in Primary Care Patients to Assess Low Vitamin B12 Status

Background: Low vitamin B12 (B12) status is common in patient populations. The timely detection and correction of low B12 prevents megaloblastic anaemia and neurological impairment. However, prompt diagnosis is recognise...

Accidental and Surreptitious Intake of Oral Anticoagulants Including Older and Newer Agents - A Diagnostic Dilemma

The newer oral anticoagulants including dabigatran, rivaraxoban, apixaban and edoxaban are replacing warfarin in the management of atrial fibrillation and venous thromboembolism. Accidental and surreptitious overdose of...

Download PDF file
  • EP ID EP246388
  • DOI 10.13188/2380-6842.1000004
  • Views 148
  • Downloads 0

How To Cite

Paolo Prandoni (2015). Residual Clot in Patients with Deep Vein Thrombosis and Pulmonary Embolism: Prognostic Implications. Journal of Hematology & Thrombosis, 1(1), 1-3. https://europub.co.uk/articles/-A-246388